The First Affiliated Hospital Of Guangzhou Medical University
Clinical trials sponsored by The First Affiliated Hospital Of Guangzhou Medical University, explained in plain language.
-
New drug aims to fix dangerous blood problems caused by cancer immunotherapy
Disease control Not yet recruitingThis study tests a drug called golidocitinib in 16 people with advanced lung cancer who have severe, hard-to-treat blood problems caused by immunotherapy. The goal is to see if the drug can safely reverse these blood side effects. Participants must not have had cancer growth in t…
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated May 17, 2026 04:17 UTC
-
New breathing strategy during lung transplant may speed recovery in seniors
Disease control Not yet recruitingThis study looks at whether letting patients breathe on their own during lung transplant surgery helps them recover faster. It involves 60 adults aged 70 and older with end-stage lung disease. The goal is to see if this approach reduces the need for a breathing machine after surg…
Phase: NA • Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New strategy aims to help frail lung transplant patients breathe easier after surgery
Disease control Not yet recruitingThis study looks at whether keeping patients breathing on their own during and after lung transplant surgery can help very underweight people recover faster. It will include 56 adults with end-stage lung disease and a very low body mass index. The main goals are to see if fewer p…
Phase: NA • Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New breathing technique may boost lung transplant recovery
Disease control Not yet recruitingThis study looks at whether a special anesthesia and surgery method that helps patients breathe on their own during a lung transplant can speed up recovery and improve survival. About 40 adults with end-stage lung disease who need a rescue transplant will take part. The main goal…
Phase: NA • Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New combo therapy targets lung cancer brain tumors in early trial
Disease control Not yet recruitingThis study tests a new targeted drug (limertinib) combined with radiation therapy as a first treatment for people with a specific type of lung cancer (EGFR-mutant non-small cell lung cancer) that has spread to the brain. The goal is to see if the combination can better control br…
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
Breathing in a Cancer-Fighting gene: new trial for lung nodules
Disease control Not yet recruitingThis study tests if inhaling a gene therapy called Gendicine can shrink or eliminate multiple ground-glass lung nodules, which are often precancerous. About 38 adults with these nodules will receive the treatment through a nebulizer. Doctors will monitor nodule changes with CT sc…
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated May 11, 2026 20:38 UTC
-
Breathing without a tube: new lung transplant strategy aims for speedier recovery
Disease control Not yet recruitingThis study tests a new anesthesia and surgery method that lets lung transplant patients breathe on their own during and after the operation, avoiding a breathing tube. Researchers want to see if this 'tubeless' approach helps patients leave the hospital sooner and stay safe. Abou…
Phase: NA • Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated May 08, 2026 12:01 UTC
-
Immune cell combo shows promise in shrinking lung tumors before surgery
Disease control Not yet recruitingThis early-phase study tests a new treatment for people with operable non-small cell lung cancer. It combines NK010 immune cells, an immunotherapy drug (PD-1 antibody), and standard chemotherapy given before surgery to shrink tumors. The main goals are to check safety and see how…
Phase: PHASE1 • Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated May 08, 2026 12:00 UTC
-
New hope for hard-to-treat lung cancer: drug combo targets HER2 mutations
Disease control Not yet recruitingThis study tests a combination of two drugs (SHR-A1811 and pertuzumab) in 60 adults with advanced non-small cell lung cancer that has a specific change called HER2 alteration and has worsened after at least one prior treatment. The goal is to see if the combo can shrink tumors or…
Phase: NA • Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated May 04, 2026 16:22 UTC
-
Shingles vaccine may boost survival in lung cancer patients
Prevention Not yet recruitingThis study looks at whether the shingles vaccine can prevent shingles and improve survival in 500 adults with lung cancer. Participants will be observed for 12 months to see who gets shingles and how long they live. The goal is to find out if this vaccine is safe and effective fo…
Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Prevention
Last updated May 17, 2026 04:34 UTC
-
No tube, better recovery? new study tests Chest-Tube-Free lung surgery
Symptom relief Not yet recruitingThis study looks at whether leaving out the chest tube after keyhole lung surgery helps patients recover faster and feel less pain. About 300 adults having surgery for lung nodules will be randomly assigned to one of three groups: standard chest tube, one suction, or two suctions…
Phase: NA • Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Symptom relief
Last updated May 17, 2026 04:40 UTC
-
No tubes, faster recovery: new lung surgery trial aims to change standard care
Symptom relief Not yet recruitingThis study tests whether avoiding breathing tubes and chest drains during minimally invasive lung surgery helps people recover faster. 138 adults with small lung nodules will be randomly assigned to either the tubeless approach or standard care. The main goal is to see if more pe…
Phase: NA • Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Symptom relief
Last updated May 17, 2026 04:36 UTC
-
Could skipping the breathing tube make esophageal cancer surgery safer?
Symptom relief Not yet recruitingThis study tests whether using a laryngeal mask instead of a breathing tube during minimally invasive esophageal cancer surgery can reduce complications and speed up recovery. About 500 adults with resectable esophageal cancer will be randomly assigned to one of two anesthesia me…
Phase: NA • Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Symptom relief
Last updated May 17, 2026 04:34 UTC
-
Herbal granule aims to ease lung symptoms in bronchiectasis patients
Symptom relief Not yet recruitingThis study tests whether a Chinese herbal medicine called Lifei Qingchang Granules can help people with stable bronchiectasis breathe easier and feel better. About 150 adults aged 18-75 who have had at least one flare-up in the past year will take either the granules or a placebo…
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Symptom relief
Last updated May 14, 2026 12:02 UTC
-
Could breathing on your own during lung surgery lead to faster recovery?
Symptom relief Not yet recruitingThis study compares a newer anesthesia method where patients breathe on their own during lung surgery to the traditional method using a breathing tube and machine. About 1,600 adults with small lung nodules will be randomly assigned to one of the two methods. The goal is to see i…
Phase: NA • Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Symptom relief
Last updated May 11, 2026 20:53 UTC
-
Robots and keyhole surgery join forces to tackle multiple lung nodules
Symptom relief Not yet recruitingThis study tests a new way to treat people who have several lung nodules. It combines robot-assisted CT-guided ablation (using heat to destroy some nodules) with a less invasive keyhole surgery (NiVATS) to remove the main nodule, all during one hospital stay. The goal is to see i…
Phase: NA • Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Symptom relief
Last updated May 08, 2026 12:03 UTC